GGHC
RCKT icon

Gilder Gagnon Howe & Co’s Rocket Pharmaceuticals RCKT Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22,510
Closed -$55.1K – 260
2025
Q2 		$55.1K Buy
+22,510
New +$114K ﹤0.01% 237
2024
Q2 		– Sell
-19,270
Closed -$519K – 270
2024
Q1 		$519K Sell
19,270
-109
-0.6% -$3.1K 0.01% 242
2023
Q4 		$581K Buy
19,379
+475
+3% +$10.5K 0.01% 222
2023
Q3 		$387K Sell
18,904
-4,484
-19% -$81.5K 0.01% 234
2023
Q2 		$465K Sell
23,388
-60
-0.3% -$1.21K 0.01% 250
2023
Q1 		$402K Buy
23,448
+3,299
+16% +$64.6K 0.01% 226
2022
Q4 		$394K Buy
+20,149
New +$371K 0.01% 221
2022
Q3 		– Sell
-29,659
Closed -$408K – 255
2022
Q2 		$408K Buy
+29,659
New +$354K 0.01% 229

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $315M AUM 54.4% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return